×
About 615 results

ALLMedicine™ C-terminal Telopeptide Center

Research & Reviews  231 results

Practical Considerations for the Clinical Application of Bone Turnover Markers in Osteo...
https://doi.org/10.1007/s00223-021-00930-4 10.1007/s001980070002 10.1515/CCLM.2011.602 10.1002/jbmr.3873 10.1210/jcem.77.4.8104954 10.1016/j.cca.2019.11.012 10.1177/18.7.473 10.1007/s00223-001-2122-7 10.1007/s00223-009-9309-8 10.1359/JBMR.040603 10.3109/10408369109106867 10.1007/s11154-014-9307-7 10.1016/j.clinbiochem.2012.03.023 10.1084/jem.179.2.405 10.1016/S0021-9258(19)83673-6 10.1002/jbmr.5650111011 10.1016/S0272-6386(03)00203-8 10.1016/j.bone.2003.04.002 10.1016/j.kisu.2017.04.001 10.1007/s00774-015-0698-7 10.4158/GL-2020-0524SUPPL 10.1177/000456329403100310 10.3109/00365519709099408 10.1007/s00198-020-05362-8 10.1007/s00198-017-4082-4 10.1016/j.cca.2020.12.023 10.1016/j.cca.2006.08.021 10.1093/clinchem/46.4.469 10.1359/jbmr.2000.15.7.1337 10.1007/s00198-017-4026-z 10.1038/s41598-021-87393-7 10.1177/00045632211003941 10.1530/EJE-17-0585 10.1007/s12325-019-01063-9 10.1530/EJE-19-0970 10.1007/s00198-015-3145-7 10.1007/s00198-014-2646-0 10.1002/jbmr.2708 10.1210/clinem/dgaa756 10.1016/j.bonr.2021.101068 10.1016/j.bonr.2021.101090 10.1007/s00198-018-4376-1 10.1002/jcph.1774 10.1038/s41598-020-59143-8 10.1038/sj.ki.5000414 10.1053/j.ajkd.2015.06.023 10.1681/ASN.2017050584 10.1097/TP.0000000000000903 10.1093/ndt/gft275 10.1046/j.1523-1755.2001.00794.x 10.1177/00045632211025567 10.1016/j.cca.2013.07.016 10.1111/j.1365-2265.2008.03187.x 10.2215/CJN.09470913 10.1111/cen.1207 10.1007/s00223-008-9127-4 10.1093/ndt/gfy306 10.21767/2472-5056.100030 10.1016/j.joms.2014.04.031 10.1002/jbmr.253 10.1016/j.joms.2007.08.003
Calcified Tissue International; Vasikaran SD, Miura M et. al.

Dec 1st, 2021 - Bone turnover markers (BTMs) are released during the bone remodelling cycle and are measurable in blood or urine, reflecting bone remodelling rate. They have been useful in elucidating the pharmacodynamics and effectiveness of osteoporosis medicat...

Biomarker-based assessment of collagen cross-linking identifies patients at risk of hea...
https://doi.org/10.1002/ejhf.2394
European Journal of Heart Failure; Ravassa S, López B et. al.

Nov 30th, 2021 - The HOMAGE randomised trial found that spironolactone reduced left atrial volume index (LAVI), E:A ratio, and a marker of collagen type I synthesis (PICP) in patients at risk of heart failure (HF). Previous trials showed that patients with HF, pre...

Bone Impairment in a Large Cohort of Chinese Patients with Tumor-induced Osteomalacia A...
https://doi.org/10.1002/jbmr.4476
Journal of Bone and Mineral Research : the Official Journ... Ni X, Feng Y et. al.

Nov 20th, 2021 - Tumor-induced osteomalacia TIO is a rare paraneoplastic syndrome caused by excessive production of fibroblast growth factor 23 FGF23 by a tumor. Previous studies have revealed generalized mineralization defects and low areal bone mineral density a...

The Effects of Milk Supplementation on Bone Health Indices in Adults: A Meta-analysis o...
https://doi.org/10.1093/advances/nmab136
Advances in Nutrition (Bethesda, Md.); Hidayat K, Chen JS et. al.

Nov 19th, 2021 - Milk contains a number of bone-beneficial nutrients. However, milk, due to D-galactose contents, might have unfavorable effects on bone health. A meta-analysis of randomized controlled trials (RCTs) was performed to clarify the effects of milk sup...

Bone Microarchitecture in Men With Hemophilia
https://clinicaltrials.gov/ct2/show/NCT05127681

Nov 19th, 2021 - Hemophilia A and B are hereditary sex-linked deficiencies of coagulation factors VIII and IX characterized by bleeding. Their modern therapy increases life expectancy and risk of age-related diseases, e.g., osteoporosis. Hemophilia-specific risk f...

see more →

Guidelines  1 results

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY...
https://doi.org/10.4158/EP161435.GL
Endocrine Practice : Official Journal of the American Col... Camacho PM, Petak SM et. al.

Sep 24th, 2016 - AACE = American Association of Clinical Endocrinologists AFF = atypical femur fracture ASBMR = American Society for Bone and Mineral Research BEL = best evidence level BMD = bone mineral density BTM = bone turnover marker CBC = complete blood coun...

see more →

Clinicaltrials.gov  4 results

Bone Microarchitecture in Men With Hemophilia
https://clinicaltrials.gov/ct2/show/NCT05127681

Nov 19th, 2021 - Hemophilia A and B are hereditary sex-linked deficiencies of coagulation factors VIII and IX characterized by bleeding. Their modern therapy increases life expectancy and risk of age-related diseases, e.g., osteoporosis. Hemophilia-specific risk f...

Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations.
https://clinicaltrials.gov/ct2/show/NCT03958565

Nov 8th, 2021 - This is an observational study involving two arms of NSCLC with metastatic bony disease at the time of enrollment in the study. One group will have an actionable driver oncogene and initiate treatment in any line with a TKI as standard of care and...

Roflumilast on Markers of Bone Metabolism and Endothelial Function in COPD
https://clinicaltrials.gov/ct2/show/NCT01745848

Aug 29th, 2017 - Study participants will be given Roflumilast 500 micrograms daily for 30 days. At baseline, prior to drug administration, blood samples will be collected for analysis of markers of bone metabolism (C-terminal telopeptide of Type I Collagen (CTx), ...

The Change of Bone Markers After Low Dose Alendronate in Postmenopausal Women With Bone Loss
https://clinicaltrials.gov/ct2/show/NCT00460057

Aug 5th, 2014 - High bone turnover with the bone resorption exceeding bone formation is a major mechanism of postmenopausal osteoporosis. Therefore, inhibition of bone resorption is a rational approach for the prevention. The Objective of the current study was to...

see more →

News  10 results

Lumbar Epidural Steroid Jab Lowers Bone Formation in Older Women
https://www.medscape.com/viewarticle/960948

Oct 15th, 2021 - Among postmenopausal women who received an epidural steroid injection (ESI) in the lumbar spine to treat back and leg pain arising from a compressed nerve in the spine, levels of bone formation biomarkers were decreased. The decrease in levels per...

Denosumab Favored Over Alendronate for BMD Protection in Glucocorticoid-Induced Osteoporosis
https://www.medscape.com/viewarticle/940923

Nov 13th, 2020 - Denosumab boosted bone mineral density (BMD) over 12 months to a greater extent than did alendronate in a randomized, 12-month study. The investigator-initiated research compared BMD at the lumbar spine and elsewhere among people with systemic lup...

Treatment Sequence With Romosozumab Influences Osteoporosis Outcomes
https://www.staging.medscape.com/viewarticle/940675

Nov 10th, 2020 - Timing is everything when it comes to the use of the anabolic agent romosozumab (Evenity) for the treatment of advanced osteoporosis, a review of clinical trials suggests. In four studies with treatment sequences in which romosozumab was administe...

Zoledronate After Denosumab Does Not Fully Prevent Bone Loss
https://www.medscape.com/viewarticle/932540

Jun 18th, 2020 - NEW YORK (Reuters Health) - In postmenopausal women and men treated for at least two years with denosumab, a single infusion of zoledronate given after denosumab discontinuation does not completely prevent bone turnover and loss, researchers say. ...

Cabozantinib Bests Everolimus in RCC with Bone Metastases
https://www.medpagetoday.com/hematologyoncology/renalcellcarcinoma/70501

Jan 14th, 2018 - Action Points Note that this post-hoc subgroup analysis of a clinical trial found that cabozantinib was superior to everolimus in terms of progression-free survival in patients with bone-metastatic renal cell carcinoma. Small subgroup analyses lik...

see more →